Last reviewed · How we verify
Placebo: corn starch
Corn starch serves as an inert placebo with no active pharmacological mechanism.
At a glance
| Generic name | Placebo: corn starch |
|---|---|
| Sponsor | Gachon University Gil Oriental Medical Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Corn starch is a biologically inert carbohydrate used as a control substance in clinical trials. It has no known molecular targets or therapeutic activity and is used to establish baseline efficacy through comparison with active treatments in blinded study designs.
Approved indications
Common side effects
- No expected adverse events (inert substance)
Key clinical trials
- Effects of Probiotics on Respiratory Tract Infections in Children: A Randomized, Placebo-Controlled Interventional Study (PHASE2)
- IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes (PHASE3)
- Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease (PHASE2)
- Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients (PHASE2)
- Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis (PHASE2)
- Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome (PHASE2)
- Caffeine Supplementation and Strength Endurance in Brazilian Jiu-jitsu Athletes (NA)
- L-serine and Strength Training in the Elderly (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |